Successful management of microscopic residual disease in large bowel cancer

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 43, Issue , 1999, Pages

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

5 Fluorouracil; Colorectal cancer; Hyperthermia; Intra peritoneal chemotherapy; Mitomycin C; Peritoneal carcinomatosis

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ABDOMINAL SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CONFERENCE PAPER; HUMAN; LYMPHADENECTOMY; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0033021563     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051093     Document Type: Conference Paper

References (25)

1. Anthone G, Brophy M, Fals J, Vukasin P, Ortega A, Ross R, Beart RW (1998) Does designated surgical interest improve the surgical management of colorectal cancer? Work done at University of Southern California. Presented at the Annual Meeting of the American Society of Colon and Rectal Surgeons, 1998
2. Averbach AM, Jacquet P, Sugarbaker PH (1995) Surgical technique and colorectal cancer: Impaction on local recurrence and survival. Tumori 81 [Suppl]: 65
3. Cole WH, Roberts SS, Strehl FW (1966) Modern concepts in cancer of the colon and rectum. Cancer 19: 1347
4. Gomez Portilla A, Sugarbaker PH, Chang D (1999) Second-look surgery after cytoreductive and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg 23: 23
5. Gomez Portilla G, Deraco M, Sugarbaker PH (1997) Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer: guidelines for current practice. Tumori 83 [Suppl]: 725
6. Gunderson LL, Sosin H (1974) Areas of failure found at re-operation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 34: 1278
7. Heald RJ, Ryall RDH (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet I: 1479
8. Hermanek P, Wieblet H, Staimmer D, Riedl S, and the German Study Group Colo-Rectal Carcinoma (1995) Prognostic factors of rectum carcinoma - experience of the German multicentre study SGCRC. Tumori 81 [Suppl]: 60
9. Holm T, Johansson H, Cedermark B, Ekelund, G, Rutqvist LE (1997) Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without pre-operative radiotherapy. Br J Surg 84: 657
10. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer, Boston, p 359
11. McArdle CS, Hole D (1991) Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br J Surg 302: 1501
12. Phillips RKS, Hittinger R, Blesovsky L, Fry JS, Fielding LP (1984) Local recurrence following "curative" surgery for large bowel cancer: I. The overall picture. Br J Surg 71: 12
13. Pickren JW, Tsukada Y, Lane WW (1982) Liver metastasis: analysis of autopsy data. In: Weiss L, Gilbert HA (eds) Liver metastasis. G.K. Hall, Boston, p 2
14. Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227: 157
15. Scott N, Jackson P, Al-Jaberi, Dixon MF, Quirke P, Finan PJ (1995) Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 82: 1031
16. Stephens AD, Sugarbaker PH (1998) Morbidity and mortality of cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy with mitomycin C using the coliseum technique. In: Bismuth H, Jalmiche JP, Huguur M, Jarck D. 8th World Congress of the International Gastro-Surgical Club. Monduzzi Editore, Bologna, p. 893
17. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221: 29
18. Sugarbaker PH (1996) Laser-mode electrosurgery. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer, Boston, p. 375
19. Sugarbaker PH (1996) Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: drugs and diseases. Kluwer, Boston, p 149
20. Sugarbaker PH (1999) Management of peritoneal surface malignancy: appendix cancer and pseudomyxoma peritonei, colon cancer, gastric cancer, abdominopelvic sarcoma, and primary peritoneal malignancy. In: Bland KI, Daly JM, Karakousis CP (eds) Surgical oncology: contemporary principles and practice. Appleton and Lange, Stamford
21. Sugarbaker PH (ed) (1998) Intraperitoneal chemotherapy and cytoreductive surgery: a manual for physicians and nurses, third edition. The Ludann Company, Grand Rapids, MI
22. Sugarbaker PH, Chang D, Koslowe P (1996) Peritoneal carcinomatosis from appendiceal cancer: a paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy. Acta Chir Austriaca 28: 4
23. Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Meyers CE (1985) Prospective randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer Surgery 98: 414
24. Sugarbaker PH, Schellinx MET, Chang D, Koslowe P, von Meyerfeldt M (1996) Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 20: 585
25. Turnbull RB, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 166: 420